PRTC
PureTech Health plc
NASDAQ · Healthcare · Biotechnology · US
$17.38
+2.12%Margins
Gross margin
-196.2%
EBITDA margin
-642.7%
EBIT margin
-2615.4%
Net margin
-624.6%
FCF margin
-2445.5%
-17.9%
Return on equity
-10.5%
Return on assets
-70.7%
Return on invested capital
0.02x
Asset turnover
-$219.2M
Cash from operations
$11
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025